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Abstract
Background We recently conducted a systematic review of
the methodological quality of randomised controlled trials
(RCTs) in plastic surgery. In accordance with convention,
we are here separately reporting a systematic review of the
reporting quality of the same RCTs.
Methods MEDLINE® and the Cochrane Database of Sys-
tematic Reviews were searched by an information specialist
from 1 January 2009 to 30 June 2011 for the MESH heading
‘Surgery, Plastic’. Limitations were entered for English lan-
guage, human studies and randomised controlled trials. Manual
searching for RCTs involving surgical techniqueswas performed
within the results. Scoring of the eligible papers was performed
against the 23-item CONSORT Statement checklist.
Independent secondary scoring was then performed and discrep-
ancies resolved through consensus.
Results Fifty-seven papers met the inclusion criteria. The
median CONSORT score was 11.5 out of 23 items (range
5.3–21.0). Items where compliance was poorest included
intervention/comparator details (7 %), randomisation imple-
mentation (11 %) and blinding (26 %). Journal 2010 impact
factor or number of authors did not significantly correlate with
CONSORT score (Spearman rho=0.25 and 0.12, respective-
ly). Only 61 % declared conflicts of interest, 75 % permission
from an ethics review committee, 47 % declared sources of
funding and 16 % stated a trial registry number. There was no
correlation between the volume of RCTs performed in a
particular country and reporting quality.
Conclusions The reporting quality of RCTs in plastic surgery
needs improvement. Better education, awareness amongst all
stakeholders and hard-wiring compliance through elec-
tronic journal submission systems could be the way
forward. We call for the international plastic surgical
community to work together on these long-standing
problems.
Keywords Randomised controlled trials . Research
methodology . Reporting quality . Consort . Levels of
evidence
Introduction
Randomised controlled trials (RCTs) represent the criterion
standard in evaluating healthcare interventions. However, RCTs
can yield biased results if they lack methodological rigour [1],
especially where surgical techniques are involved [2]. Readers
need complete, clear and transparent information in order to
assess a trial accurately. Unfortunately, many trials fail to
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provide critical information in published reports [3–5]. Inad-
equately reported RCTs are associated with bias in estimat-
ing the effectiveness of interventions and with poor meth-
odology [6–12].
The Consolidated Standards of Reporting Trials statement
was originally developed in 1996 [13] to aid reporting of
RCTs, and an extension for non-pharmacological interven-
tions (CONSORT NPT) was published in 2008 [14]. It con-
sists of a 23-item checklist and flow diagram.
Our team have previously assessed the methodological
quality of recent RCTs in plastic surgery, concluding that it
requires improvement [15]. However, although flaws in meth-
odology limit the validity and generalizability of study results,
without accurate reporting, shortcomings in study design and
implementation can be compounded and become difficult
to accurately assess. Studies looking at methodological
quality are usually separate from reporting quality [16].
Given this previous work, the purpose of this new study
is to systematically review the reporting quality of recent
RCTs in plastic surgery using CONSORT NPT criteria.
This new work will allow the plastic surgical community
to take stock of where reporting quality has been in recent
years.
Material and methods
Search methods
The search technique was the same as used for this team’s
previous work assessing the methodological quality of plastic
surgery RCTs [15]. An information specialist (trained in da-
tabase searching by NHS Evidence, who conducts approxi-
mately 100 searches per year and is the staff trainer) based at
the lead authors Plastic Surgery Unit searched MEDLINE®
and the Cochrane Database of Systematic Reviews from 1
January 2009 to 30 June 2011 for the Medical Subject Head-
ings (MESH is the NLM controlled vocabulary thesaurus used
for indexing articles for PubMed) ‘Surgery, Plastic’ or ‘Re-
constructive Surgical Procedures’ with ‘or’ used as a Boolean
operator and with the ‘explode’ function activated. We chose
this time period since the CONSORTNPTstatement was only
published in 2008 and hence it would be unfair to hold RCTs
prior to this period to a standard that did not exist at the time of
writing. Limitations were set for the English language, human
studies and randomised controlled trials.
Results were then manually searched by four of us
(ED, MS, CFC and EE) for relevant RCTs involving
surgical techniques. Papers involving purely pharmaco-
logical therapies in all arms, cost analyses, study proto-
cols, interim or non-randomised studies, short commu-
nications and RCTs involving virtual or simulated pro-
cedures were excluded.
Scoring
The papers were then scored by one of three primary scorers
(ED, MS, EE) against the 23-item CONSORT NPT checklist
with each item being given an equal weighting. Items 4 and
11 were subdivided into four and three sub-parts, respec-
tively; a full point was only gained if all sub-parts were
fulfilled; otherwise, the appropriate fraction was awarded.
The resulting mark out of 23 was termed the ‘CONSORT
score’. Following this initial round of scoring (ED scored
2009, MS scored 2010 and 2011), all papers were then re-
scored by a single secondary scorer (CFC). Discrepancies
were then resolved by consensus (between ED, MS and
CFC), and if that could not be reached, they were referred
to the lead author (RA) for a final judgement. Evaluators were
not blinded to the country of origin of the authors.
Compliance with individual items of the statement was
analysed (by summating the number of articles fulfilling that
item divided by the total number of included articles) as well
as the relationship between CONSORT score and year of
publication, geographical origin (for the RCT), the number
authors and the ISI 2010 impact factor for the journals in
which the RCTs were published. These additional correlates
were chosen to give information about whether improvements
are occurring over time and whether volume and perceived
markers of RCT quality (like impact factor of the journal in
which it is published) correlate with actual reporting quality as
defined by CONSORT.
Secondary analyses
In addition to the CONSORT score, papers were assessed for
whether they fulfilled seven additional criteria referred to in
the CONSORT NPT and whether they mention conflicts of
interest, sources of finding, a trial registry number and ethical
approval.
Statistical analysis
In line with previous work [15], inter-rater agreement was
assessed using the Kappa score. Data were analysed using
non-parametric descriptors such as median, and correlations
were calculated using Spearman rho, using SPSS version 20.
Results
The search history was as follows:
1. MEDLINE; exp SURGERY, PLASTIC/; 25,698 results
2. MEDLINE; exp RECONSTRUCTIVE SURGICAL
PROCEDURES/; 52,999 results
3. MEDLINE; 1 OR 2; 76,741 results
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4. MEDLINE; 3 [Limit to: Publication Year 2009–2011 and
English Language]; 11,395 results
5. MEDLINE; 4 [Limit to: (Publication Types Randomized
Controlled Trial) and Publication Year 2009–2011 and
English Language]; 254 results
From the initial set of 254 papers retrieved fromMEDLINE,
63 were selected following a manual search and abstract assess-
ment by the authors (ED, MS, CFC). Subsequent to complete
download of all 63 papers, six were excluded for being a study
protocol, purely pharmacological or theoretical, retrospective or
an interim study. This resulted in 57 RCTs which met the
inclusion criteria (seven were multicentre), published across
28 journals. All RCTs compared treatment interventions and
none related to diagnosis. No further relevant trials were
found in the Cochrane Database of Systematic Reviews
(Fig. 1).
The median CONSORT score was 11.5 out of 23 items
(range 4.5–21.0) with a Kappa score 0.80. There was a
slight trend for improvement over the 3-year period, on
average 1.5 CONSORT points per year (Spearman rho 0.999)
(see Table 1).
Compliance with individual items of the CONSORT
Compliance was highly variable for the different CONSORT
items. This is shown in Fig. 2. Compliance was the poorest
for items related to intervention/comparator details (7 %),
randomisation implementation (11 %) and blinding (26 %),
as shown in Table 2.
Compliance with additional criteria
There was poor fulfilment of additional criteria and only
61 % declared conflicts of interest, 75 % permission
Fig. 1 PRISMA flow diagram,
illustrating how papers were
selected (adapted from Moher
et al. [17])
Table 1 Summary statistics for CONSORT scores per year
Year Number of RCTs Median CONSORT score Range
2009 26 9.9 4.5–17.3
2010 21 11.5 5.3–21.0
2011a 10 12.9 9.0–15.0
a To 30 June 2011 only
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Fig. 2 Compliance of the 57
RCTs with the individual items
of the CONSORT statement
Table 2 Compliance of RCTs
with individual items of the
CONSORT statement (ranked in
order of increasing fulfilment)
Consort table adapted from
Moher et al. [7]
Criteria Abbreviated description Compliance (%)
New item (23) Details of the experimental treatment and comparator as they were
implemented
7
10 Who generated the allocation sequence, who enrolled participants and
who assigned participants to their groups
11
11 Whether or not participants, those administering the interventions and
those assessing the outcomes were blinded to group assignment
26
16 Number of participants (denominator) in each group included in each
analysis and whether analysis was by ‘intention-to-treat’
27
1 How participants were allocated to interventions—is it mentioned in
the title
31
7 How sample size was determined and, when applicable, explanation of
any interim analyses and stopping rules
31
13 Flow of participants through each stage (a diagram is strongly recommended) 38
18 Address multiplicity by reporting any other analyses performed, including
subgroup analyses and adjusted analyses, indicating those prespecified
and those exploratory
38
8 Method used to generate the random allocation sequence, including details
of any restriction (e.g. blocking, stratification)
40
9 Method used to implement the random allocation sequence, clarifying
whether the sequence was concealed until interventions were assigned
40
21 Generalizability (external validity) of the trial findings 45
4 Precise details of the interventions intended for each group and how and
when they were actually administered
52
14 Dates defining the periods of recruitment and follow-up 56
6 Clearly defined primary and secondary outcome measures 62
19 All important adverse events or side effects in each intervention group 64
15 Baseline demographic and clinical characteristics of each group 65
3 Eligibility criteria for participants and the settings and locations where
the data were collected
69
5 Specific objectives and hypotheses 71
20 Interpretation of the results, taking into account study hypotheses, sources
of potential bias or imprecision
75
12 Statistical methods used to compare groups for primary outcome(s);
methods for additional analyses, such as subgroup analyses and
adjusted analyses
76
17 For each primary and secondary outcome, a summary of results for
each group and the estimated effect size and its precision
78
22 General interpretation of the results in the context of current evidence 89
2 Scientific background and explanation of rationale 98
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from an ethics review committee, 47 % declared sources of
funding and just 16 % stated a trial registry number (Table 3).
CONSORT score and number of authors
There was no correlation between number of authors and
CONSORT score (Spearman rho=0.12, see Fig. 3).
CONSORT score and impact factor
There was no correlation between journal impact factor and
CONSORT score (Spearman rho=0.26, see Fig. 4).
Geographical distribution of RCTs and CONSORT
compliance
There was no correlation between the volume of RCTs
conducted in a particular country and CONSORTscore (Fig. 5).
Discussion
Over the last decade, there have been increasing calls for
utilising an evidence-based medicine approach within surgery
[18, 19]. However, the evidence base in plastic surgery is still
dominated by case series, and calls for higher levels of evi-
dence (including RCTs) are gathering pace [20, 21]. Poor
reporting ‘short circuits’ proper critical appraisal prevents
inclusion in systematic reviews and meta-analyses, and
resulting clinical judgements could be misleading and poten-
tially dangerous.
Previous reviews of surgical RCTs have shown that, in
20 %, the conclusions were not justified by the data [22].
Solomon et al. found that the lowest quality RCTs were those
that involved a surgical technique, were published in a surgi-
cal journal and where a surgeon was the principal author [23].
Research in the field of RCT reporting quality has pointed
to the consistent absence of the same key quality data:
sample size calculations, randomisation sequence generation
method and implementation, post-randomisation verification
of balance in known confounders, allocation concealment,
blinding, intention-to-treat analysis and participant flow
charts. Our study is the first to assess the compliance of
recent RCTs in plastic surgery with the CONSORT NPT
criteria, and the results support this pattern of poor compli-
ance with a low median CONSORT score of 11.5. This is
similar to the CONSORT scores (out of 22) found in earlier
work by one of us (RAA), with 11.1 for Urological RCTs,
10.3 for cardiac surgery, 10.9 for general surgery, 11.9 for
hepatobiliary, 10.8 for orthopaedic and 12.0 for vascular
surgery [19]. Furthermore, the additional CONSORT NPT
criteria were severely lacking (Table 3). Whilst they are not
core criteria, the authors recognise them as important for
RCTs of interventions. Poor reporting has also been linked
with poor methodology as shown by Taghinia et al. [24]
and others [8–12].
Fig. 3 CONSORT score against
number of authors
Table 3 Compliance of RCTs with additional criteria
Additional criteria Compliance (%)
AD1—eligibility criteria for care providers 7
AD2—details on the centres’ volume 5
AD3—number of care providers performing the
treatment in each group
38
AD4—number of participants treated by each care
provider
31
AD5—details on patients’ expectancies or preference
for the treatments at baseline
2
AD6—baseline data of care providers 0
AD7—details on care providers’ compliance with
the planned procedure
4
Ethical approval 75
Sources of funding 47
Trial registry number 16
Conflicts of interest 61
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Studies with more authors have been correlated with higher
citation levels [25]. One would anticipate that more authors on
a study would lead to better reporting quality; however, our
research did not support this, consistent with earlier work [19].
There was also no correlation between CONSORT score and
the impact factor of the journal in which the RCT was pub-
lished, again consistent with earlier work by one of us (RA)
[19]. The impact factor is heralded by many plastic surgeons
and editors [26] as the reflection of increasing journal and
article quality. Yet successive studies are now showing that it
has no bearing on the quality of reporting of one of the highest
levels of evidence—the RCT. Sinha et al. [27] identified the
top three ranked surgical journals by impact factor and found
that, of 42 RCTs analysed, only 40% had a Jadad score ≥3 and
there was no significant difference between CONSORT-
endorsing and non-endorsing journals. Our data showed no
link between volume of RCTs from a particular geographic
region and CONSORT score. This suggests that the problems
of poor reporting are indeed global and not confined to a few
select countries.
Within plastic surgery specifically, several studies have
found that RCTs need improvement in reporting quality.
McCarthy et al. [28] analysed level 1 studies in five plastic
surgery journals from 1978 to 2009. They found that only
Fig. 5 A bar chart of CONSORT
score and number of RCTs
against country
Fig. 4 CONSORT score against
ISI 2010 impact factor
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39 % reported randomisation technique. In their analysis of
96 RCTs in plastic surgery published between 2004 and
2008, Veiga et al. [29] found that 29 % appropriately de-
scribed allocation concealment. Momeni et al. [30] analysed
172 RCTs from three plastic surgical journals during 1990–
2005 and found that only 12 % reported on their allocation
concealment and 37 % described participant dropouts. Karri
looked at 133 RCTs published across three plastic surgery
journals from 1980 to 2004 [31]. Sample size calculation was
only reported in 12.8 % of trials, randomisation methodology
in 29.3 %, allocation concealment in 18.8 %, blinding of
investigator/assessment in 51.9 % and study limitations in
only 33.8 % trials. Veiga Filho et al. in 2005 examined 34
RCTs in plastic surgery and concluded that they were overall
of low quality with 59 % scoring two points or less on a Jadad
score [32]. In addition, they concluded that the process of
randomisation in the studies was appropriately designed and
conducted but that authors did not report it. Follow-up work
by the same group in 2011 concluded that RCT quality as
measured by Jadad criteria had ‘significantly increased’ [29].
In 2005, the International Committee of Medical Journal
Editors implemented a policy [33] that required registration of
all clinical trials prior to enrolment of the first patient (part of
the aim being a reduction in publication bias from the non-
publication of negative studies). In 2007, this became part of
US regulatory requirement with section 801 of the Food and
Drug Administration Amendments Act [34]. In 2008, trial
registration became an ethical requirement with the updated
Declaration of Helsinki mandating it [35]. Despite this, only
16 % of RCTs in our sample stated their trial registry. The low
reporting of conflicts of interest, sources of funding and ethical
approval is concerning; such information is pivotal scientific
and scholarly transparency and integrity.
On the positive side, there was an upward trend in the
median CONSORT score, rising three points over the 3-year
period 2009–2011. However, since all the CONSORT items
are mandatory for reporting, this increase is unlikely to be due
to a serious appreciation and compliance with CONSORT
specifically. It is more likely to be due to general improve-
ments in reporting that may be occurring or simply random.
The limitations of our study include restriction to the En-
glish language, searching only MEDLINE® and analysing
papers by publication date rather than submission date, since
publication lag times for journals vary. The English language
has increasingly become the lingua franca of science with an
estimated 80–90 % of papers in scientific journals written in
English [36]. This has been coupled with initiatives to offer
translation services of key papers [37]. We feel that this
strategy would still capture all the relevant papers. Whilst
we did not blind our evaluators to the country of origin of
the authors, we do not feel there was any inherent bias
against a particular country and scores were recorded in a
dispassionate manner.
Further work is needed to assess barriers to compliance with
CONSORT amongst key stakeholders in the process: authors,
journal reviewers and editors, funders, institutions and readers.
Meticulous planning, involvement of a trial methodologist,
biostatistician and compliance with CONSORT NPT in the
eventual paper would be key for those conducting and
reporting RCTs. Journal editors and peer reviewers as guard-
ians of the scholarly literature have an important gatekeeper
role here [38, 39].
We support previous calls for the better education of plastic
surgeons at all levels in clinical research methods, evidence-
based medicine and improved funding/support of plastic sur-
gical RCTs. McCulloch et al. [40] have called for the deploy-
ment of alternative prospective designs, such as interrupted
time series studies, to be used when randomised trials are not
feasible—we support their call and indeed suggest that regis-
try studies may be useful in some instances.
One solution is to hard-wire compliance with CONSORT
by making the checklist a mandatory item for submission if a
manuscript is submitted as an RCT. It can also be published as
a supplementary item online allowing for greater transparency
and scrutiny by readers. Such a policy was adopted by the
International Journal of Surgery in January 2013 [41].
Conclusion
The reporting quality of RCTs in plastic surgery requires
improvement. Perceived surrogate markers of quality such
as number of authors and impact factor of the journal had no
relationship on CONSORTcompliance. We suggest ways this
could be improved including better education, awareness
amongst all stakeholders and hard-wiring compliance through
electronic journal submission systems.
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